Case Report
Copyright ©The Author(s) 2020.
World J Gastroenterol. Jan 28, 2020; 26(4): 448-455
Published online Jan 28, 2020. doi: 10.3748/wjg.v26.i4.448
Figure 1
Figure 1 Liver function tests from the time of liver transplant. PTA: Percutaneous transluminal angioplasty; LFT: Liver function test; AST: Aspartate aminotransferase; ALT: Alanine aminotransferase; AP: Antipsychotics.
Figure 2
Figure 2 Images of doppler ultrasound in the main hepatic artery. A: Doppler ultrasound in the main hepatic artery prior to intervention (day 80 post-transplant) demonstrating parvus et tardus waveform with low resistive index and low peak systolic velocity; B: After stenting (day 115 post-transplant, day 15 post stenting) showing normal waveform, normal peak systolic velocity, and normal resistive index.
Figure 3
Figure 3 Images of computed tomography angiogram. A: Computed tomography angiogram performed 60 d post-transplant showing small and irregular proper hepatic artery with stenosis (arrow); B: Ninety days post-transplant, showing small and irregular proper hepatic artery with stenosis (arrow); C and D: Hepatic artery angiography on post-transplant day 91 revealed a tight stenosis around a hairpin turn (white arrow) treated effectively with percutaneous transluminal angioplasty.
Figure 4
Figure 4 Angiography on day 100 post-transplant. A: Angiography on day 100 post-transplant showed recurrent hepatic artery stenosis (arrow, insert); B and C: Balloon dilation (arrowheads) performed within the hairpin turn did not resolve the stenosis (C, arrow); D: Synchro support wire passed distally for stability (arrowhead) with advancement of Navien support catheter (arrow); E: Wingspan stent advanced around hairpin. Stent end markers are easily visualized (double head arrows); F: Post-stent angiography demonstrates resolution of the stenosis (arrow) and brisk flow into the hepatic arteries.